Tarek Nafee

Tarek Nafee

Auto-generated profile, based on publicly available information

Tarek Nafee

Saint Louis University, Saint Louis, MO, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2020 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
TNTarek Nafee
Tarek Nafee
CGC. Michael Gibson
C. Michael Gibson
RTRyan Travis
Ryan Travis
MYMegan K. Yee
Megan K. Yee
MKMathieu Kerneis
Mathieu Kerneis
SGSamuel Z. Goldhaber
Samuel Z. Goldhaber
Background The identification of acutely ill patients at high risk for venous thromboembolism (VTE) may be determined clinically or by use of integer‐based scoring systems. These scores demonstrated modest performance in external data sets. Objectives To evaluate the performance of machine learning models compared to the IMPROVE score. Methods The APEX trial randomized 7513 acutely medically ill patients to extended duration betrixaban vs. enoxaparin. Including 68 variables, a super learner model (ML) was built to predict VTE by combining estimates from 5 families of candidate models. A “reduced” model (rML) was also developed using 16 variables that were thought, a priori, to be associated with VTE. The IMPROVE score was calculated for each patient. Model performance was assessed by discrimination and calibration to predict a composite VTE end point. The frequency of predicted risks of VTE were plotted and divided into tertiles. VTE risks were compared across tertiles. Results The ML and rML algorithms outperformed the IMPROVE score in predicting VTE (c‐statistic: 0.69, 0.68 and 0.59, respectively). The Hosmer‐Lemeshow goodness‐of‐fit P‐value was 0.06 for ML, 0.44 for rML, and <0.001 for the IMPROVE score. The observed event rate in the lowest tertile was 2.5%, 4.8% in tertile 2, and 11.4% in the highest tertile. Patients in the highest tertile of VTE risk had a 5‐fold increase in odds of VTE compared to the lowest tertile. Conclusion The super learner algorithms improved discrimination and calibration compared to the IMPROVE score for predicting VTE in acute medically ill patients.

1 August 2018 in The American Journal of Medicine
Verified
Journal Article
Closed access
GCGerald Chi
Gerald Chi
CGC. Michael Gibson
C. Michael Gibson
AHAdrian F. Hernandez
Adrian F. Hernandez
RHRussell D. Hull
Russell D. Hull
SKSyed Hassan A. Kazmi
Syed Hassan A. Kazmi
SGSamuel Z. Goldhaber
Samuel Z. Goldhaber

1 October 2023 in Cardiology Plus
Verified
Journal Article
Open access
TNTarek Nafee
Tarek Nafee
ASAreeb Shah
Areeb Shah
MFMichael Forsberg
Michael Forsberg
JZJingsheng Zheng
Jingsheng Zheng
JOJiafu Ou
Jiafu Ou
The history of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) reflects the relentless pursuit of innovation in interventional cardiology. These intravascular imaging technologies have played a pivotal role in our understanding of coronary atherosclerosis, vascular pathology, and the interaction of coronary stents with the vessel wall. Two decades of clinical investigations demonstrating the clinical efficacy and safety of intravascular imaging modalities have established these technologies as staples in the contemporary cardiac catheterization lab’s toolbox and earning their place in revascularization clinical practice guidelines. In this comprehensive review, we will delve into the historical evolution, mechanisms, and technical aspects of IVUS and OCT. We will discuss the expanding evidence supporting their use in complex percutaneous coronary interventions, emphasizing their crucial roles in optimizing patient outcomes and ensuring procedural success. Furthermore, we will explore the substantial advances that have propelled these imaging modalities to the forefront of contemporary interventional cardiology. Finally, we will survey the latest developments in the field and explore the promising future directions that have the potential to further revolutionize coronary interventions.

1 March 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
FAFahad Alkhalfan
Fahad Alkhalfan
TNTarek Nafee
Tarek Nafee
MYMegan K. Yee
Megan K. Yee
GCGerald Chi
Gerald Chi
AKArzu Kalayci
Arzu Kalayci
C Michael GibsonC Michael Gibson
C Michael Gibson

1 March 2017 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
TATomas Andriotti
Tomas Andriotti
RSRafaelly Stavale
Rafaelly Stavale
TNTarek Nafee
Tarek Nafee
SFStephanie Fakhry
Stephanie Fakhry
MMMahmoud M.A. Mohamed
Mahmoud M.A. Mohamed
RBRaphael Boechat-Barros
Raphael Boechat-Barros
Postpartum Depression affects a considerable number of women worldwide. This condition inflicts severe consequences to mother and child health. Thus far, available treatments have low response and high relapse rates. We designed this trial to evaluate a safe and more efficacious innovative therapy. To report a feasible and ethical study design to assess the safety and efficacy of a high frequency repetitive Transcranial Magnetic Stimulation 10 Hz (rTMS) compared to sham rTMS in women with moderate to severe Post-Partum Depression using standard treatment (sertraline).To conduct an ancillary, exploratory, randomized, active controlled, double blind study with a hypothesis to assess the safety and efficacy of 10 Hz rTMS compared to sertraline. A multicenter, parallel arm, randomized, placebo-controlled, double-blind design to assess safety and efficacy of 10 Hz rTMS compared to sham.An ancillary study will be conducted with parallel arm, randomized, active controlled and double dummy design to assess safety and efficacy of 10 Hz rTMS compared to sertraline.

25 April 2025 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Open access
PDF file
TNTarek Nafee
Tarek Nafee
KHKishore J. Harjai
Kishore J. Harjai
CLChien-Jung Lin
Chien-Jung Lin